CN106174171A - A kind of red Fructus Lycii buccal tablet and preparation method thereof - Google Patents
A kind of red Fructus Lycii buccal tablet and preparation method thereof Download PDFInfo
- Publication number
- CN106174171A CN106174171A CN201610518170.8A CN201610518170A CN106174171A CN 106174171 A CN106174171 A CN 106174171A CN 201610518170 A CN201610518170 A CN 201610518170A CN 106174171 A CN106174171 A CN 106174171A
- Authority
- CN
- China
- Prior art keywords
- fructus lycii
- buccal tablet
- red
- powder
- sweeting agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 45
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 33
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 14
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 12
- 150000001746 carotenes Chemical class 0.000 claims abstract description 12
- 235000005473 carotenes Nutrition 0.000 claims abstract description 12
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000013336 milk Nutrition 0.000 claims abstract description 11
- 239000008267 milk Substances 0.000 claims abstract description 11
- 210000004080 milk Anatomy 0.000 claims abstract description 11
- 229920002472 Starch Polymers 0.000 claims abstract description 10
- 235000019698 starch Nutrition 0.000 claims abstract description 10
- 239000008107 starch Substances 0.000 claims abstract description 10
- 229930006000 Sucrose Natural products 0.000 claims abstract description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 8
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 7
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 7
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 7
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 7
- 239000008187 granular material Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000080 wetting agent Substances 0.000 claims description 7
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims description 6
- 229940085605 saccharin sodium Drugs 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 5
- 239000000605 aspartame Substances 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 5
- 229960003438 aspartame Drugs 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 229940013618 stevioside Drugs 0.000 claims description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 5
- 235000019202 steviosides Nutrition 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 2
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 238000010791 quenching Methods 0.000 abstract description 3
- 230000035922 thirst Effects 0.000 abstract description 3
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 230000036528 appetite Effects 0.000 abstract 1
- 235000019789 appetite Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 description 25
- 244000241838 Lycium barbarum Species 0.000 description 10
- 235000015459 Lycium barbarum Nutrition 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 235000015468 Lycium chinense Nutrition 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 244000241872 Lycium chinense Species 0.000 description 4
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 4
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 206010000059 abdominal discomfort Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- -1 carotenoid ester Chemical class 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 2
- 235000011649 selenium Nutrition 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 244000038582 Lasianthus lucidus Species 0.000 description 1
- 235000015463 Lycium carolinianum Nutrition 0.000 description 1
- 241000169546 Lycium ruthenicum Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- NEEHYRZPVYRGPP-IYEMJOQQSA-L calcium gluconate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O NEEHYRZPVYRGPP-IYEMJOQQSA-L 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000015177 dried meat Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015149 toffees Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000011514 vinification Methods 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of red Fructus Lycii buccal tablet and preparation method thereof, described buccal tablet comprises: red Fructus Lycii powder 30%, starch 50%, maltodextrin 5%, milk powder 5%, red date powder 3%, carotene 1%, white sugar 3%, sweeting agent 1%, citric acid 0.5%, magnesium stearate 1.5%.This buccal tablet is nutritious, in good taste, can invigorating the spleen and replenishing QI, appetite promoting and the spleen strengthening；Can QI invigorating essence by force, nourishing the liver and kidney, only quench one's thirst, skin care, the effect of defying age.
Description
Technical field
The invention belongs to field of health care food, be specifically related to a kind of red Fructus Lycii buccal tablet and preparation method thereof.
Background technology
Fructus Lycii (Barbary Wolfberry Fruit) is the mature fruit of matrimony vine of solanaceae plant.Fructus Lycii passes in China
Having consequence in system medical science, its medical value enjoys the high praise of ancient Chinese medicine doctor, is tradition rare Chinese medicine and nutrition taste
Tonic.Containing lycium barbarum polysaccharide (LBP), glycine betaine (betaine), carotenoid ester, vitamin C, scopoletin in Fructus Lycii
(scopoletin), the element such as several amino acids and K, Na, Ca, Mg, Cu, Fe, Mn, Zn, P, have abundant nutritive value and
Special medical care effect.It has many effects such as essence strengthening and the kidney invigorating, nourishing the liver to improve visual acuity, lung moistening of enriching blood.Fructus Lycii contains abundant
The antioxidant such as lycium barbarum polysaccharide, beta-carotene, vitamin E, selenium and flavonoid, have preferable antioxidation.Fructus Lycii can
To free radical resisting peroxidating, alleviate free radical peroxide injury, thus contribute to slow down aging, extend the life-span." legendary god of farming's book on Chinese herbal medicine
Warp " in be classified as top grade, successive dynasties physician thinks Fructus Lycii " sweet, sour, flat ", have nourishing the liver and kidney, enrich blood, lung moistening, strong
Essence effect such as bone, improving eyesight.
At present, the Fructus Lycii class medical and health-care products on domestic market mainly has drinks, medicine class, food beverages and natural juice class
Deng.The Fructus Lycii food being developed into has Red beer contg. Chinese wolf-berry wine, soft sweet Fructus Lycii dried apricot dried meat, L.Lucidus Turcz. wolfberry juice, Aloe-medlar Beverage, Fructus Lycii core
Fructus Persicae breast and Fructus Lycii (parched with Mel) milk etc..Wherein the exploitation of lycium barbarum product has defined five more than 30 kinds of big series, and Fructus Lycii class is produced
Product be extend to the industries such as wine-making industry, beverage/food and nutrient and healthcare products by traditional Chinese crude drug category, successively develops Fructus Lycii
Dry fruit, fresh juice beverage of matrimony vine, Lycium chinense wine, wolfberry fruit sauce, Fructus Lycii extra dry red wine, Fructus Lycii tea, Fructus Lycii toffee, Wolf-berry capsules, Fructus Lycii shortcake volume,
Chinese wolfberry soyabean milk powder, instant Chinese wolfberry-soya-bean milk granules, Chinese wolfberry and coffee, wolfberry juice, aminoacid Fructus Lycii rich in selenium phospholipid wine, boxthorn seed oil, lycium barbarum polysaccharide,
The products such as Fructus Lycii lyophilized powder, Fructus Lycii normal-temperature fresh-keeping natural juice and Fructus Lycii crystal sugar.
Although the kind of Fructus Lycii product is more, but owing to the sugar content of Fructus Lycii is higher, it is difficult to preserve for a long time, add production work
Technology problem, and confusion and the people of health-product market in recent years accept the most equal of attitude to health product so that Chinese holly
Qi series products can not dominate the market in a large number.At present, the subject matter that Fructus Lycii series products exists is: (1) low-level repetition phenomenon is tight
Weight, product specification is low, scientific and technological content is low, and China's health food mostly is first generation product at present, lacks the experimental basis of science, and
Kind is dull, shares general product many, and tailored version product is few；(2) product is of low quality, and Product processing degree is low, commodity
Change degree and technology content are the most relatively low, and it is poor to pack, some important nutrient wretched insufficiency or do not have in product, product attached
Value added little；(3) supervision and oversight of production process is not tight, and working condition is poor, and the enterprise that scientific and technological level is the highest is more, enterprise
The innovation ability of industry is not strong, and product structure can not adaptation to market variations demand.
Radix Dauci Sativae contains substantial amounts of carotene, and the molecular structure of carotene is equivalent to the vitamin A of 2 molecules, Radix Dauci Sativae
After element enters body, through the effect of enzyme in liver and mucous membrane of small intestine, wherein the carotene of 50% becomes vitamin A, has benefit
The effect of liver improving eyesight, it is also possible to treatment nyctalopia；Possibly together with Plant fiber in Radix Dauci Sativae, water absorption is strong, and in intestinal, volume is easy
Expand, be " full material " in intestinal, can strengthen the wriggling of intestinal, thus profit diaphragm width intestinal, relieving constipation gives protection against cancer；Vitamin A is bone
The required material that bone normal growth is grown, contributes to cell proliferation and growth, is the key element of body growth, to promoting infant
Growth promoter is significant；Can strengthen immune function of human body, carotene is transformed into vitamin A, contributes to enhancing body
Immunologic function, prevention epithelial cell canceration during there is important function.Lignin in Radix Dauci Sativae also can improve body
Immunologic function, eliminates cancerous cell indirectly；Radix Dauci Sativae, possibly together with sugar reducing substance, is the good food of diabetes patient, contained therein certain
A little compositions, as Quercetin, kaempferol can increase coronary artery blood flow, reduce blood fat, promote adrenergic synthesis, also have fall
Pressure, cardiotonic, is the dietetic therapy good merchantable brand of hypertension, patients with coronary heart disease.
Fructus Jujubae is the mature fruit of jujube, and through drying in the air, shine or toast drying forming, peel is red to aubergine.Have another name called China
Fructus Jujubae, originates in China, so far the cultivation history of more than 3000 year, is one of distinctive fruit tree of China, is the most becoming China
New hot-spot for development in fruit tree.With " five fruit " of Lee, Fructus Pruni, Fructus Persicae, chestnut referred to as China, there is blood replenishing and stomach nourishing, invigorating the spleen and replenishing QI, supplement
Effect of polysaccharide.
CN104585662 discloses the preparation method of a kind of Fructus Lycii, red date lozenge, it is characterised in that comprise the steps:
(1) selection: by weight, selects high-quality lycium barbarum 30 parts, Lingwu, Ningxia long red date 10 parts, 10 parts of Ningxia Radix Glycyrrhizae, Fructus Crataegi 15
Part, Cortex Cinnamomi 6 parts, 15 parts of Rhizoma Zingiberis Recens, the Radix Astragali 30 parts, it is respectively washed clean, dries and be uniformly mixed so as to obtain mixture；(2) pulverize: use Chinese medicine
Mixture in step (1) is pulverized by pulverizer, and 100 mesh sieves excessively obtain powder；(3) water carries: in step (2), powder adds 30
Times distilled water, extracts 2h with thermostat water bath 60 DEG C, crosses leaching filtrate for the first time, and filtering residue adds 20 times of distilled water extraction 1h,
Cross leaching second time filtrate, merge filtrate for the first time and obtain mixture extracting solution with second time filtrate；(4) concentrate: by step (3)
In mixture extracting solution stand after 5-20h, be evaporated to the extractum that relative density is 1.20-1.25, and it be dry to continue decompression
The dry cream of dry one-tenth, and dried cream powder is broken into fine powder, standby after crossing 90 mesh sieves；(5) pelletize: by Icing Sugar, soluble starch respectively through 50
DEG C crushed after being dried, crosses 90 mesh sieves after pulverizing, cross 90 mesh sieves, by fine powder and Fructus Vitis viniferae in step (4) after being ground by calcium gluconate
Calciofon mixes according to the ratio of 3.7:1, then by weight 1:1:1, this mixture is added Icing Sugar and soluble starch, then
Spray into 60% appropriate amount of ethanol, be sufficiently mixed uniformly, cross 16 mesh sieves and pelletize, 40 DEG C of dry 4h, obtain yellowish-brown granule；(6) tabletting:
Granule adds according to mass percent in step (5) citric acid, the 2%PEG6000 of 1%, after mix homogeneously, uses tablet machine
Beat sheet, buccal tablet can be obtained.
Summary of the invention
The invention provides a kind of red Fructus Lycii buccal tablet, this buccal tablet comprises red Fructus Lycii powder 25-35%, starch 45-55%, Fructus Hordei Germinatus
Dextrin 4-6%, milk powder 4-6%, red date powder 2-4%, carotene 0.5-2%, white sugar 2-4%, sweeting agent 0.5-1.5%, Fructus Citri Limoniae
Acid 0.3-0.6% and magnesium stearate 1.0-2.0%, be all weight percentage.
Preferably, the red Fructus Lycii buccal tablet of the present invention, comprise red Fructus Lycii powder 30%, starch 50%, maltodextrin 5%, milk powder
5%, red date powder 3%, carotene 1%, white sugar 3%, sweeting agent 1%, citric acid 0.5% and magnesium stearate 1.5%.
The buccal tablet of the invention described above, described sweeting agent is stevioside, saccharin sodium or aspartame.
Present invention also offers the preparation method of the red Fructus Lycii buccal tablet of a kind of the invention described above, comprise the following steps:
1) red Fructus Lycii and Fructus Jujubae cleaned, dry, distinguish micronizing；
2) by after the red Fructus Lycii of micronizing and Fructus Jujubae mixing, starch, carotene, maltodextrin, milk powder, red is added
After date powder, white sugar, sweeting agent, citric acid and magnesium stearate mix homogeneously, add wetting agent pelletize, be dried granule；
3) by dried granule granulate, sieve, then by granulation i.e. buccal tablet.
The method of the invention described above, described wetting agent is selected from purified water or 60% ethanol solution, preferably purified water, described sweet
Taste agent is stevioside, saccharin sodium or aspartame.
The method of the invention described above, in step 1) in, sterilize after also including red Fructus Lycii and Fructus Jujubae are cleaned.
The method of the invention described above, the raw material employed in step 2 can cross 80 mesh sieves, and make that raw material keeps being suitable for is thin
Degree, in step 3) described granulate is by 20 mesh sieves.
The red Fructus Lycii buccal tablet of the present invention, has the effect that
1) product of the present invention is nutritious, in good taste, fine and smooth, containing Fructus Lycii, Fructus Jujubae, carotin compound nutritional composition；Long
Phase drinks this product, can invigorating the spleen and replenishing QI, nourishing the stomach, can QI invigorating essence by force, nourishing the liver and kidney, improving eyesight, defying age, only quench one's thirst, warming up body, anti-
Control hypertension and heart disease.Long-term drink also has change cold body constitution, the effect of life lengthening, it is crucial that be easy to take
Band, taking convenience.The buccal tablet of the present invention can preserve for a long time, does not goes mouldy.
Detailed description of the invention
Following example are in order to be further appreciated by the essence of the present invention, but limit the scope of the present invention never in any form.
Embodiment 1 red Fructus Lycii buccal tablet
Preparation technology:
1) red Fructus Lycii and Fructus Jujubae are cleaned, sterilizing, dry, micronizing respectively, sieve and obtain red Fructus Lycii powder and red date powder；
2) by after the red Fructus Lycii powder of micronizing and red date powder mixing, then by starch, carotene, maltodextrin, milk powder,
White sugar, sweeting agent (stevioside), citric acid and magnesium stearate cross 80 mesh sieves respectively, then mix with red Fructus Lycii powder and red date powder
After Jun Yun, add appropriate wetting agent purified water pelletize, be dried granule；
3) by dried granule granulate, sieve, then by granulation i.e. buccal tablet；
4) buccal tablet is tested, qualified rear packaging finished product warehouse-in.
Every tablet weight 1-2g of buccal tablet.
Embodiment 2-4 red Fructus Lycii buccal tablet
The formula of embodiment 2-4 see table 1
Table 1 embodiment 2-4 containing slice prescription
Preparation technology is with reference to embodiment 1, wherein, wetting agent: embodiment 2 with 60% ethanol, embodiment 3-4 purification
Water.Sweeting agent: embodiment 2 uses saccharin sodium, embodiment 3 and 4 to use aspartame.
The wetting agent purified water of comparative example 1-2, the sweeting agent of comparative example 1-2 uses saccharin sodium.
Preparation technology is with reference to embodiment 1.
Product quality detects
The Testing index of the buccal tablet of the buccal tablet of embodiment 1-4 and comparative example 1-2 (formula is shown in Table 1), detection method is field
Conventional method.
1.1, organoleptic indicator's testing result of the buccal tablet of embodiment 1-4 is shown in Table 2.1:
Table 2.1 organoleptic indicator's testing result
| Project | Index request |
| Color and luster | Uniformity, meets the due color and luster of this product |
| Tissue morphology | Sheet shape is complete, in the same size, without unfilled corner, crack, smooth surface |
| Flavour abnormal smells from the patient | There is the due flavour of this product and abnormal smells from the patient, free from extraneous odour |
| Impurity | The exogenous impurity being visible by naked eyes, 12-24 month without mildew |
Organoleptic indicator's testing result of the buccal tablet of 1.2 comparative examples 1-2 is shown in Table 2.2.
Table 2.2 comparative example buccal tablet organoleptic indicator's testing result
Showing from the data of upper table 2.1 and 2.2, the buccal tablet indices of the present invention meets the requirements, and the containing of comparative example 1-2
But there is sliver, size heterogeneity and spottiness in sheet, deposits 3-6 month and mildew occurs.
2, the physical and chemical index testing result of the buccal tablet of embodiment 1-4 is shown in Table 3:
Table 3 physical and chemical index testing result
| Detection project | Testing index |
| Moisture % | ≤12 |
| Total sugar % | / |
| Lead (in terms of Pb) mg/kg | ≤1 |
| Arsenic (in terms of As) mg/kg | ≤0.5 |
3, the microbiological indicator testing result of the buccal tablet of embodiment 1-4 is shown in Table 4:
Table 4 microbiological indicator testing result
Comparative example 3 Fructus Lycii buccal tablet
The black structure Qi of embodiment 1 and the micropowder of Fructus Jujubae are respectively with reference to CN104585662 structure Qi and the water extracted immersing paste of Fructus Jujubae
The black structure Qi for preparing of method and Fructus Jujubae extractum replace, and extractum is broken into powder, the method with reference to embodiment 1 is pressed into buccal tablet.
Effect:
King X flood, man 56 years old, symptom: kidney yin is lost, soreness of the waist and knees, dizzy, dizzy, cough due to consumptive disease, quench one's thirst.Take embodiment 1
Buccal tablet, 2 times on the one, a buccal 1-2 sheet, after 3 months, transference cure, without adverse side effect.
Zhao X covers, man 38 years old, symptom: soreness of the waist and knees, and seminal emission is dizzy, dizzy.Take the buccal tablet of embodiment 1,2 times on the one,
Buccal 1-2 sheet, after 2 months, transference cure.In high spirits, have a good complexion, eyes have god, without adverse side effect.
Wu X is fragrant, female 45 years old, symptom: disposition, breathe hard, have a stomachache, body is cold, complexion is bad.Take the buccal tablet of embodiment 1, one day
2 times, a buccal 1-2 sheet, after 3 months, transference cure.Have a good complexion, without disposition, phenomenon of breathing hard, stomach the most bitterly, do not recur, no
It is afraid of cold, without adverse side effect.
King's X brightness, man, 40 years old, kidney yin was lost, soreness of the waist and knees, and seminal emission, dizziness are dizzy.Take the buccal tablet 2 times on the one of comparative example,
Buccal 1-2 sheet, after 3 months, remission disappears, transference cure after 6 months, but has the phenomenon of stomach upset.
Wu X virtue, female 41 years old, symptom: cardiopalmus, breathe hard, body is cold, complexion is bad, cough.Take the buccal tablet of comparative example, one day 2
Secondary, a buccal 1-2 sheet, after taking 4 months, symptom is improved.Transference cure after taking 6 months, without cardiopalmus, phenomenon of breathing hard, but
There is the side effect of stomach upset.
Above effect example is only the representative of the user of the buccal tablet of numerous present invention.The buccal tablet of the present invention is in good taste, carefully
Greasy, produce without side reaction.And comparative example has and takes patient and the reaction of stomach upset occur.And mouthfeel has granular sensation.
After the buccal tablet of embodiment 2-4 is to patient's long-term taking, it may have effect same as in Example 1.
The buccal tablet of the present invention is relative to the buccal tablet table in terms of curative effect and side reaction extracting extractum by Lycium ruthenicum Murr. and Fructus Jujubae
Reveal obvious advantage.
Claims (7)
1. a red Fructus Lycii buccal tablet, comprise red Fructus Lycii powder 25-35%, starch 45-55%, maltodextrin 4-6%, milk powder 4-6%,
Red date powder 2-4%, carotene 0.5-2%, white sugar 2-4%, sweeting agent 0.5-1.5%, citric acid 0.3-0.6% and stearic acid
Magnesium 1.0-2.0%, is all weight percentage.
2. buccal tablet as claimed in claim 1, comprises red Fructus Lycii powder 30%, starch 50%, maltodextrin 5%, milk powder 5%, red
Date powder 3%, carotene 1%, white sugar 3%, sweeting agent 1%, citric acid 0.5% and magnesium stearate 1.5%.
3. buccal tablet as claimed in claim 1 or 2, described sweeting agent is stevioside, saccharin sodium or aspartame.
4. the method preparing the red Fructus Lycii buccal tablet of claim 1 or 2, comprises the following steps:
1) red Fructus Lycii and Fructus Jujubae cleaned, dry, distinguish micronizing；
2) by after the red Fructus Lycii of micronizing and Fructus Jujubae mixing, add starch, carotene, maltodextrin, milk powder, red date powder,
After white sugar, sweeting agent, citric acid and magnesium stearate mix homogeneously, add wetting agent pelletize, be dried granule；
3) by dried granule granulate, sieve, then by granulation i.e. buccal tablet.
5. method as claimed in claim 4, described wetting agent is selected from purified water or 60% ethanol solution.
6. method as claimed in claim 4, described sweeting agent is stevioside, saccharin sodium or aspartame.
7. method as claimed in claim 4, in step 1) in, carry out sterilizing after also including red Fructus Lycii and Fructus Jujubae are cleaned.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610518170.8A CN106174171A (en) | 2016-07-04 | 2016-07-04 | A kind of red Fructus Lycii buccal tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610518170.8A CN106174171A (en) | 2016-07-04 | 2016-07-04 | A kind of red Fructus Lycii buccal tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106174171A true CN106174171A (en) | 2016-12-07 |
Family
ID=57465447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610518170.8A Pending CN106174171A (en) | 2016-07-04 | 2016-07-04 | A kind of red Fructus Lycii buccal tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106174171A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107625913A (en) * | 2017-09-29 | 2018-01-26 | 杞源堂（宁夏）生物科技有限公司 | A kind of red matrimony vine lozenge of selenium-rich and preparation method thereof |
| CN107751871A (en) * | 2017-09-29 | 2018-03-06 | 杞源堂（宁夏）生物科技有限公司 | A kind of selenium-rich lycium ruthenicum lozenge and preparation method thereof |
| CN109259211A (en) * | 2018-09-12 | 2019-01-25 | 北京化工大学 | A kind of preparation method of low sugar red date powder |
| CN109645135A (en) * | 2019-01-21 | 2019-04-19 | 西北师范大学 | A kind of preparation method of fructus lycii donkey milk piece |
| CN109744495A (en) * | 2017-11-06 | 2019-05-14 | 天津万品科技有限公司 | A kind of lycium ruthenicum honey lozenge and preparation method thereof |
| CN110179113A (en) * | 2019-05-16 | 2019-08-30 | 云南万兴隆生物科技集团有限公司 | A kind of compound nutritional ginger lozenge and its processing technology |
| CN115517350A (en) * | 2021-06-25 | 2022-12-27 | 中国农业大学 | A nutritional milk tablet containing protein and soluble fiber |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105707875A (en) * | 2016-04-12 | 2016-06-29 | 宁夏曼苏尔清真食品有限公司 | Red and black fructus lycii lozenges and preparation method thereof |
-
2016
- 2016-07-04 CN CN201610518170.8A patent/CN106174171A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105707875A (en) * | 2016-04-12 | 2016-06-29 | 宁夏曼苏尔清真食品有限公司 | Red and black fructus lycii lozenges and preparation method thereof |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107625913A (en) * | 2017-09-29 | 2018-01-26 | 杞源堂（宁夏）生物科技有限公司 | A kind of red matrimony vine lozenge of selenium-rich and preparation method thereof |
| CN107751871A (en) * | 2017-09-29 | 2018-03-06 | 杞源堂（宁夏）生物科技有限公司 | A kind of selenium-rich lycium ruthenicum lozenge and preparation method thereof |
| CN109744495A (en) * | 2017-11-06 | 2019-05-14 | 天津万品科技有限公司 | A kind of lycium ruthenicum honey lozenge and preparation method thereof |
| CN109259211A (en) * | 2018-09-12 | 2019-01-25 | 北京化工大学 | A kind of preparation method of low sugar red date powder |
| CN109645135A (en) * | 2019-01-21 | 2019-04-19 | 西北师范大学 | A kind of preparation method of fructus lycii donkey milk piece |
| CN110179113A (en) * | 2019-05-16 | 2019-08-30 | 云南万兴隆生物科技集团有限公司 | A kind of compound nutritional ginger lozenge and its processing technology |
| CN115517350A (en) * | 2021-06-25 | 2022-12-27 | 中国农业大学 | A nutritional milk tablet containing protein and soluble fiber |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106174171A (en) | A kind of red Fructus Lycii buccal tablet and preparation method thereof | |
| CN106072143A (en) | A kind of Lycium ruthenicum Murr. buccal tablet and preparation method thereof | |
| CN103610183A (en) | Beverage for preventing excessive internal heat and preparation method thereof | |
| CN103387899A (en) | Black tea wine and production method thereof | |
| CN110226688A (en) | A kind of mulberries rhizoma polygonati drink and preparation method thereof | |
| CN106173695A (en) | A kind of sapodilla Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN104312875A (en) | Preparation method of millet tonic wine | |
| CN107541403A (en) | A kind of yellow peach fruit wine and production method | |
| CN104893919A (en) | Preparation method of maize nourishing wine | |
| CN104886696A (en) | Ganoderma lucidum fetus protecting fruit vinegar drink | |
| KR101834638B1 (en) | The method of functional korea traditional cracker using the jujube | |
| CN106256220A (en) | A kind of Fructus Mangifera Indicae Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN105876557A (en) | Radix Puerariae liver protecting beverage and preparation method thereof | |
| CN106234889A (en) | A kind of Punica granatum L. Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN106107309A (en) | A kind of Fructus Fragariae Ananssae Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN108813229A (en) | A kind of bamboo juice health drink and preparation method thereof | |
| CN107125513A (en) | A kind of compound juice beverage with functions of strengthening stomach and promoting digestion and preparation method thereof | |
| CN106234874A (en) | A kind of fruit of Radix et Caulis Opuntiae Dillenii Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN106578916A (en) | Production method of mulberry and bombyx mori noodles and production method of byproduct namely mulberry wine | |
| CN106213380A (en) | A kind of compound nectar and preparation method thereof | |
| CN106261328A (en) | A kind of Fructus Citri grandis Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN106261372A (en) | A kind of Fructus Ananadis comosi certain kind of berries Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN105876556A (en) | Radix Puerariae summer-heat expelling beverage and preparation method thereof | |
| CN106173693A (en) | A kind of Fructus Artocarpi Heterophylli Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN106261319A (en) | A kind of Fructus Fortunellae Margaritae Herba Passiflorae Caeruleae mulse and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |